Tilray Brands (NASDAQ:TLRY) Trading Up 1.9% - Time to Buy?

Key Points

• Intraday move: Tilray Brands (NASDAQ:TLRY) jumped 1.9% to about $7.35 on Monday with 3.22M shares traded, roughly 21% below its average session volume and below its 50‑day and 200‑day moving averages of $8.29 and $10.95.
• Analyst consensus: The stock carries an average rating of "Hold" (one Buy, six Holds, one Sell) and a consensus price target of $13.33, amid mixed recent analyst actions including both upgrades and price‑target cuts.
• Fundamentals: Latest quarter showed an EPS beat ($-0.02 vs. -$0.14) and revenue of $217.5M, but the company remains unprofitable with a negative net margin (~251.7%) and an expected FY EPS of about -0.2.

Tilray Brands, Inc. (NASDAQ:TLRY - Get Free Report) shares shot up 1.9% during mid-day trading on Monday . The company traded as high as $7.40 and last traded at $7.35. 3,223,481 shares traded hands during mid-day trading, a decline of 21% from the average session volume of 4,082,578 shares. The stock had previously closed at $7.21.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on TLRY shares. ATB Cormark Capital Markets raised shares of Tilray Brands from a "strong sell" rating to a "hold" rating in a report on Wednesday, December 10th. Roth Mkm cut their price objective on shares of Tilray Brands from $20.00 to $10.00 and set a "neutral" rating on the stock in a report on Tuesday, January 20th. Wall Street Zen cut Tilray Brands from a "hold" rating to a "sell" rating in a report on Saturday. Zacks Research raised shares of Tilray Brands from a "strong sell" rating to a "hold" rating in a research note on Wednesday, February 11th. Finally, Weiss Ratings reiterated a "sell (d-)" rating on shares of Tilray Brands in a report on Wednesday, January 21st. One analyst has rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $13.33.

Tilray Brands Price Performance

The company has a market capitalization of $856.35 million, a price-to-earnings ratio of -0.33 and a beta of 1.95. The business has a fifty day moving average price of $8.29 and a 200 day moving average price of $10.95. The company has a debt-to-equity ratio of 0.19, a current ratio of 2.81 and a quick ratio of 1.72.

Tilray Brands (NASDAQ:TLRY - Get Free Report) last issued its quarterly earnings results on Thursday, January 8th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.12. Tilray Brands had a negative return on equity of 6.35% and a negative net margin of 251.69%.The company had revenue of $217.51 million for the quarter, compared to analysts' expectations of $211.15 million. During the same period last year, the firm earned ($0.03) EPS. On average, research analysts expect that Tilray Brands, Inc. will post -0.2 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the stock. Hilton Head Capital Partners LLC bought a new position in Tilray Brands during the fourth quarter worth about $38,000. Engineers Gate Manager LP acquired a new stake in Tilray Brands in the fourth quarter worth about $126,000. Oppenheimer & Co. Inc. acquired a new position in Tilray Brands in the third quarter valued at approximately $25,000. Silverlake Wealth Management LLC acquired a new stake in shares of Tilray Brands during the third quarter worth $25,000. Finally, Unified Investment Management bought a new stake in Tilray Brands in the third quarter valued at approximately $26,000. 9.35% of the stock is owned by institutional investors.

Tilray Brands Company Profile

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray's product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.